PLOS One:发现引起心脏病和冠状动脉疾病又一大危险因素

2017-11-09 佚名 medicalxpress

一项新研究表明,血液中的磷酸盐与心脏病和冠状动脉疾病的风险有关。

一项新研究表明,血液中的磷酸盐与心脏病和冠状动脉疾病的风险有关。

来自萨里大学的研究人员发现,血液中磷酸盐含量不足可能会对心血管健康造成危害,这与之前在该领域的研究相矛盾,该研究认为低含量的矿物质对心脏有益。

这项研究使用了RCGP研究和监测中心的数据,研究了超过10万名患者的磷酸盐水平,超过5年和9年的时间间隔,以及对他们心脏健康的影响。研究人员发现,血液中的矿物质含量低(低于0.75 mmol/ L)的人罹患冠状动脉疾病的风险与高水平(高于1.5 mmol/ L)的风险相似。在血液中磷酸盐含量较低、浓度过高的情况下,这两种情况的情况都很好,但在中程(1 -1.25 mmol/ L)水平上的心脏事件明显减少。

在血液中与高水平的磷酸盐有关的风险已经被科学界证实,但这是第一次发现低水平的危险可能同样危险。

磷酸盐是人体重要的矿物质,有助于调节血液生化,从而影响心脏的工作。它在促进红细胞向身体组织输送氧气方面起着至关重要的作用,在蛋白质丰富的食物如肉类、家禽和鱼类中也能找到。

尼克·海沃德博士在萨里大学进行了这项研究,他说:“在初级和中级医疗中,磷酸盐的重要性应该被审查。”在血液测试中经常被忽视,但磷酸盐可能是成人心脏病的一个新的危险因素。

萨里大学的Andy McGovern博士说:“我们的发现揭示了磷酸盐在身体中的作用及其与心血管健康的关系。”根据我们的发现,我们建议临床医生认为磷酸盐水平低的人心血管疾病风险较高,并评估每个患者的降低方式。”

原始出处:

Nicholas Hayward, Andrew McGovern, Simon de Lusignan, et.al. U-shaped relationship between serum phosphate and cardiovascular risk: A retrospective cohort study. PLOS One

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1790066, encodeId=64691e90066ef, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Feb 10 21:35:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252907, encodeId=b19a125290e97, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Nov 11 10:35:00 CST 2017, time=2017-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260063, encodeId=d56226006352, content=学习了.非常好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Thu Nov 09 20:25:52 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260059, encodeId=cb4e26005994, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Thu Nov 09 20:09:37 CST 2017, time=2017-11-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1790066, encodeId=64691e90066ef, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Feb 10 21:35:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252907, encodeId=b19a125290e97, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Nov 11 10:35:00 CST 2017, time=2017-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260063, encodeId=d56226006352, content=学习了.非常好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Thu Nov 09 20:25:52 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260059, encodeId=cb4e26005994, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Thu Nov 09 20:09:37 CST 2017, time=2017-11-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1790066, encodeId=64691e90066ef, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Feb 10 21:35:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252907, encodeId=b19a125290e97, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Nov 11 10:35:00 CST 2017, time=2017-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260063, encodeId=d56226006352, content=学习了.非常好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Thu Nov 09 20:25:52 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260059, encodeId=cb4e26005994, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Thu Nov 09 20:09:37 CST 2017, time=2017-11-09, status=1, ipAttribution=)]
    2017-11-09 天涯183

    学习了.非常好的文章

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1790066, encodeId=64691e90066ef, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Feb 10 21:35:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252907, encodeId=b19a125290e97, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Nov 11 10:35:00 CST 2017, time=2017-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260063, encodeId=d56226006352, content=学习了.非常好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Thu Nov 09 20:25:52 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260059, encodeId=cb4e26005994, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Thu Nov 09 20:09:37 CST 2017, time=2017-11-09, status=1, ipAttribution=)]
    2017-11-09 天地飞扬

    谢谢分享!

    0

相关资讯

Radiology:查个冠心病,是选CT灌注还是MR灌注?

本研究旨在评价负荷心肌计算机体层成像(CT)灌注和负荷心肌磁共振(MR)灌注成像在检出冠心病(CAD)的诊断价值,并将结果发表在Radiology上。

SCI REP:冠心病筛查中餐后血糖由于空腹血糖和糖化血红蛋白!

在中国人群中,冠心病的严重程度与血糖有关,而不是胰岛素抵抗。PBG与冠心病的存在和严重程度呈正相关。

英痴呆症死亡人数首超冠心病

据英国《太阳报》(The Sun)11月8日报道,英国官方数据表明,英国越来越多的人死于痴呆症,首次超过了冠心病的死亡人数。

Eur Radiol:冠心病患者福音--通过冠脉CTA随访预测远期风险!

本研究旨在利用冠状动脉CT血管造影(CCTA)评价稳定性心绞痛患者冠状动脉粥样硬化斑块负荷进展的预测价值,并探究其与主要心血管事件(MACE)发生率的相关性,并将结果发表在Eur Radiol上。

Lancet:药物洗脱支架用于75岁以上老年冠心病患者效果优于裸金属支架

研究认为,对于接受经皮冠状动脉介入的75岁以上患者,药物洗脱支架联合短期双联抗血小板治疗相比裸金属支架联合短期双联抗血小板治疗,可降低患者全因死亡、心肌梗死、中风与缺血驱动的靶病变血运重建的发生率,同时药物洗脱支架联合短期双联抗血小板治疗可降低PCI后老年患者的出血风险

JACC:脂蛋白的糖基化水平会影响T2DM患者的冠心病发生

脂蛋白的非酶糖基化作用在糖尿病患者血管并发症的发生过程中起到重要作用。近日,在国际心血管权威杂志JACC上发表了一篇旨在评估2型糖尿病(T2DM)患者的脂蛋白(apo)A-IV是否存在糖基化,并且apoA-IV的糖基化是否与冠心病(CAD)的发生有关的临床研究。本研究纳入了204名不伴有CAD的T2DM患者(第一组),515名伴有CAD的T2DM患者(第二组)和176名正常对照。apoA-IV是从